| E-Folder |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Top7 or 10 Tips > 7 Compelling Reasons Not To Discount |
|
E-Folder - 7 Compelling Reasons Not To Discount
If you are selling a service and you only have your personal time to sell, one hundred hours is one hundred hours—and the amount of discounts According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product you give to customers can make the difference between a profitable year, or not. Unfortunately, discounting as a business practice is so entr ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in enched that I probably don't need to help you recreate the arguments that justify it. The dictionary describes the effect well: 'to deduct fr lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. om the amount, cost; to disregard; to make less effective by anticipation.' Before you succumb to the temptation to win new business by offer here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ing a discount take a moment to consider these seven problems associated with discounting:
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro tion on price—as if that were all that matters. If your only competitive advantage is price, you are in trouble, because price can always be m ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc atched. easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi to hold out the longest. nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically y will value it. and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ price—do you think your customer is going to accept any less quality? ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi compromise the quality of what you sell, you risk disappointing customers and you may lose repeat business, and lose credibility or gain a bad ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a reputation, or end up spending time fixing complaints. One way or another today's discounts could rob you of future business, and profits. dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod i> cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin potential profits in the future. tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen d 'quick fix' that reduces business growth in the long run. Before you discount, stop and think: Is this the only way to give value? t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel Be mindful when you're offering a discount. Why are you doing it? Is it an investment, and will it net you a greater financial return in the f ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust uture? Or is it something you do all the time, a thinly disguised (yet noble!) excuse for not charging your worth? Are you offering a discoun y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products t as the 'lazy way out'—instead of making the effort to explain or demonstrate your value? One of the basic rules of negotiating is that if yo . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de u are going to offer a discount, you offer a different product or service. Perhaps negotiate different terms, or a shorter guarantee, or longe elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip r lead times. Challenge your customer's proposition for a discount with: "If you want a better price, give me a better order. tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Networking For a Job-3 Areas to Look The Multiplying Factor In Sales Success
|